CoChat

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.

New therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8+ neutrophils

Open access
Guan, Yukun, Feng, Dechun, Maccioni, Luca, Wang, Yang, Gao, Bin · 2024 · eGastroenterology

Abstract

Alcohol-associated liver disease (ALD) is one of the leading chronic liver diseases worldwide, encompassing a spectrum of conditions from simple steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma.1 Histologically, alcohol-associated steatohepatitis (ASH) is characterised by lipid accumulation in hepatocytes, hepatocellular damage, ballooning of hepatocytes, formation of Mallory-Denk bodies, inflammation and pericellular fibrosis.1 Over the past several decades, research has elucidated key molecular mechanisms underlying ALD, such as ethanol-induced hepatotoxicity, oxidative stress, endoplasmic reticulum stress and organ–organ crosstalk pathways like the gut-liver and adipose tissue-liver axes.2 Patients with underlying chronic ALD, particularly those with recent episodes of excessive drinking, are at risk of developing acute alcohol-associated hepatitis (AH), a condition characterised by severe clinical symptoms, including jaundice.3 Severe AH (sAH) is commonly linked to alcohol-associated cirrhosis (AC) and carries a high short-term mortality rate. Due to the limited availability of effective pharmacological therapies, early liver transplantation is frequently required as a life-saving intervention.3 Identifying molecular mechanisms driving AH progression and liver failure is thus essential for developing targeted therapies for this life-threatening disease. AH, first described in 1961, is recognised as an acute inflammatory liver disease characterised by extensive inflammatory cell infiltration.4 Currently, AH is recognised as a form of acute-on-chronic liver injury involving various types of immune cells, including macrophages, neutrophils, T cells and B cells, as evidenced by immunohistochemical analysis.5 Recent RNA-sequencing analyses have highlighted that AH is associated with the upregulation of numerous inflammatory mediators, including pro-inflammatory cytokines, chemokines and adhesion molecules.5–7 However, the key mechanisms that drive the transition from ALD to sAH remain unclear.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/egastro-2024-100166

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 IL-8+ neutrophils induce a vicious cycle that drives unstoppable inflammation in AH. Peripheral neutrophils from sAH patients initially express low levels of IL-8. However, on infiltrating the sAH liver, these neutrophils are stimulated by the inflammatory environment, including mediators such as TNF-α and IL-1β, to produce high levels of IL-8. This IL-8 production amplifies systemic IL-8 levels, further recruiting neutrophils to the liver and perpetuating a vicious cycle of inflammation. As central drivers of this inflammatory loop, IL-8+ neutrophils represent promising therapeutic targets for managing sAH. Diagram was created with BioRender.com. AH, alcohol-associated hepatitis; IL, interleukin; sAH, severe AH; TNF, tumour necrosis factor.
Figure 1 IL-8+ neutrophils induce a vicious cycle that drives unstoppable inflammation in AH. Peripheral neutrophils from sAH patients initially express low levels of IL-8. However, on infiltrating the sAH liver, these neutrophils are stimulated by the inflammatory environment, including mediators such as TNF-α and IL-1β, to produce high levels of IL-8. This IL-8 production amplifies systemic IL-8 levels, further recruiting neutrophils to the liver and perpetuating a vicious cycle of inflammation. As central drivers of this inflammatory loop, IL-8+ neutrophils represent promising therapeutic targets for managing sAH. Diagram was created with BioRender.com. AH, alcohol-associated hepatitis; IL, interleukin; sAH, severe AH; TNF, tumour necrosis factor.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 21

Metadata

Authors
Guan, Y., Feng, D., Maccioni, L., Wang, Y., & Gao, B.
Affiliations
National Institutes of Health (US)
Corresponding author
Gao, Bin
Venue
eGastroenterology
Publisher
BMJ
Published
2024-12
Volume
2
Issue
4
Pages
e100166
ISSN
  • 2766-0125 (ISSN-L)
  • 2976-7296
OpenAlex
W4405679487
Cited by
21
References
25
Citations by year
2026: 5 · 2025: 16
FWCI
6.38
Type
journal article
Language
en
Open access
Locations
  • eGastroenterology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Clinical Center (AA000368)
  • National Institute on Alcohol Abuse and Alcoholism (AA000369)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
alcoholic hepatitis, alcoholic liver disease, alcoholic cirrhosis, neutrophil infiltration, inflammatory mediators, therapeutic target, liver failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8+ neutrophils. https://app.cochat.ai/papers/10.1136/egastro-2024-100166
The paper
Guan, Y., Feng, D., Maccioni, L., Wang, Y., & Gao, B. (2024). New therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8+ neutrophils. eGastroenterology. https://doi.org/10.1136/egastro-2024-100166

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.